Linkster Therapeutics (Switzerland)

Recent papers from Linkster Therapeutics (Switzerland)

1. FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastomaNature Communications · 2025
2. Cyclosporine A sterically inhibits statin transport by solute carrier OATP1B1Journal of Biological Chemistry · 2025
3. Flycodes enable simultaneous preclinical analysis for dozens of antibodies in single cassette–dosed miceProceedings of the National Academy of Sciences · 2025
4. Structural basis for triacylglyceride extraction from mycobacterial inner membrane by MFS transporter Rv1410Nature Communications · 2023
5. Structural basis for triacylglyceride extraction from mycobacterial inner membrane by MFS transporter Rv14102023
6. Cryo-EM structures of a LptDE transporter in complex with Pro-macrobodies offer insight into lipopolysaccharide translocationNature Communications · 2022
7. Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistanceEMBO Reports · 2022
8. Mechanistic basis of choline import involved in teichoic acids and lipopolysaccharide modification2021
9. Structural insights into glycine reuptake inhibition2020
10. Biparatopic sybody constructs neutralize SARS-CoV-2 variants of concern and mitigate emergence of drug resistance2020